RxDoctor Payments Data

Gabrielle Barkley

Physician Assistant · Exton, PANPI 1730844945

Payments from drug & device makers

$3,165in general payments, 2019–2025

Across 132 payments — averaging $23.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$560
  • AbbVie$504
  • Lilly USA, LLC$383
  • Amgen$337
  • GSK$269
  • Novo Nordisk$184
  • plus $929 from 19 others

What the payments were for

  • Food & beverage$3,165100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,165 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$55,419
BiktarvyBictegrav/Emtricit/Tenofov Ala12$48,622
JardianceEmpagliflozin28$30,653
JanuviaSitagliptin Phosphate27$21,302
EliquisApixaban14$18,643
FarxigaDapagliflozin Propanediol16$17,687
MounjaroTirzepatide13$16,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,740
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,789
Atorvastatin Calcium162$1,748
Rosuvastatin Calcium74$1,210
Losartan Potassium108$1,078
Metoprolol Succinate60$882
Albuterol Sulfate HfaAlbuterol Sulfate30$870
Levothyroxine Sodium84$822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$184$55,41956 claims
GileadBiktarvy$82$48,62212 claims
Boehringer IngelheimJardiance$98$30,65328 claims
PfizerEliquis$145$18,64314 claims
AstraZenecaFarxiga$560$17,68716 claims
Lilly USA, LLCMounjaro$383$16,44513 claims
GSKTrelegy Ellipta$269$8,74014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Exton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →